Cargando…
Lung adenocarcinoma patients with malignant pleural effusions in hot adaptive immunity status have a longer overall survival
Malignant pleural effusion (MPE) is a common complication of lung adenocarcinoma (LADC) which is associated with a dismal prognosis. We investigated the prognostic role of PD-L1 and other immunomodulators expression in the immune compartment of MPE immune composition. MPE cytologic cell blocks of 83...
Autores principales: | Wu, Cheng-Guang, Casanova, Ruben, Mairinger, Fabian, Soltermann, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577289/ https://www.ncbi.nlm.nih.gov/pubmed/36267973 http://dx.doi.org/10.3389/fonc.2022.1031094 |
Ejemplares similares
-
Prognostic Immune Cell Profiling of Malignant Pleural Effusion Patients by Computerized Immunohistochemical and Transcriptional Analysis
por: Wu, Chengguang, et al.
Publicado: (2019) -
In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening
por: Wu, Cheng-Guang, et al.
Publicado: (2020) -
Malignant pleural effusion from prostate adenocarcinoma
por: Knight, James C., et al.
Publicado: (2014) -
Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion
por: Verma, Akash, et al.
Publicado: (2016) -
Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022)